These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Filed by the Registrant
☒
|
Filed by a party other than the Registrant
☐
|
| ☐ |
Preliminary Proxy Statement
|
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
| ☒ |
Definitive Proxy Statement
|
| ☐ |
Definitive Additional Materials
|
| ☐ |
Soliciting Material Pursuant to ss. 240.14a-12
|
|
☒
|
No fee required.
|
|
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(a)(1) and 0-11.
|
|
☐
|
Fee paid previously with preliminary materials.
|
|
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
Sincerely,
|
|
|
|
|
John W. Alexander
|
|
|
Chairman of the Board
|
| I. |
The election of four directors;
|
| II. |
The ratification of the appointment of KPMG LLP as independent registered public accounting firm for the year ending December 31, 2018;
|
| III. |
An advisory, non-binding resolution, to approve the executive compensation described in the Proxy Statement; and
|
|
By Order of the Board of Directors
|
|
|
|
|
|
Woodbridge, New Jersey
|
M. Eileen Bergin
|
|
April 10, 2018
|
Senior Vice President and Corporate Secretary
|
|
Name and Address of
Beneficial Owner(s)
|
Amount of Shares
Owned and Nature of
Beneficial
Ownership
(1)
|
Percent of Shares of
Common Stock
Outstanding
|
||||||
|
Northfield Bank Employee
|
3,676,713
|
7.5
|
%
|
|||||
|
Stock Ownership Plan Trust
|
||||||||
|
2 Enterprise Drive, Suite 408
|
||||||||
|
Shelton, CT 06484
|
||||||||
|
Blackrock, Inc.
|
5,817,669
|
(2)
|
11.8
|
%
|
||||
|
55 East 52nd Street
|
||||||||
|
New York, NY 10055
|
||||||||
|
The Vanguard Group
|
4,103,309
|
(3)
|
8.4
|
%
|
||||
|
100 Vanguard Blvd.
|
||||||||
|
Malvern, PA 19355
|
||||||||
|
Dimensional Fund Advisors, LP
|
3,292,844
|
(4)
|
6.7
|
%
|
||||
|
Building One
|
||||||||
|
6300 Bee Cave Road
|
||||||||
|
Austin, TX 78746
|
||||||||
| (1) |
In accordance with Rule 13d-3 under the Exchange Act, a person or entity is deemed to be the beneficial owner for purposes of this table, of any shares of common stock if they have shared voting or investment power with respect to such security, or a right to acquire beneficial ownership at any time within 60 days from the date as of which beneficial ownership is being determined. As used herein, “voting power” is the power to vote or direct the voting of shares and “investment power” is the power to dispose or direct the disposition of shares, and includes all shares held directly as well as by spouses and minor children, in trust and other indirect ownership, over which shares the named individuals effectively exercise sole or shared voting or investment power.
|
| (2) |
This information is based on Schedule 13G/A filed with the Securities Exchange Commission on January 19, 2018.
|
| (3) |
This information is based on Schedule 13G/A filed with the Securities Exchange Commission on February 9, 2018.
|
| (4) |
This information is based on Schedule 13G/A filed with the Securities Exchange Commission on February 9, 2018.
|
|
John W. Alexander
|
Karen J. Kessler
|
|
Annette Catino
|
Steven M. Klein
|
|
Gil Chapman
|
Frank P. Patafio
|
|
John P. Connors, Jr.
|
Patrick L. Ryan
|
|
Timothy C. Harrison
|
Patrick E. Scura, Jr.
|
| · |
promote open and effective communications among the Chairman of the Board and independent members of the Board and in conjunction with the Chairman, management of the Company, including in particular the Chief Executive Officer. The role of the Lead Director also is to facilitate and promote the Board’s strength and independence;
|
| · |
convene and chair executive sessions of the independent directors at least twice annually, and other meetings as may be necessary from time to time and, as appropriate, provide prompt feedback to the Chairman of the Board and the Chief Executive Officer;
|
| · |
coordinate and develop the agenda for executive sessions of independent directors;
|
| · |
coordinate ongoing feedback to the Chairman of the Board and the Chief Executive Officer on behalf of independent directors regarding business issues and management;
|
| · |
coordinate and develop with the Chairman of the Board the agendas for meetings of the Board and informational needs associated with those agendas and presentations;
|
| · |
identify and develop with the Chairman of the Board and the Nominating and Corporate Governance Committee, the Board’s compositional needs and criteria for director candidates;
|
| · |
coordinate with legal counsel, responses to questions and/or concerns from stockholders or other interested parties that were communicated or addressed to the Company’s independent directors; and
|
| · |
perform such other duties as may be necessary for the Board to fulfill its responsibilities or as may be requested by the Board as a whole, by the non-management directors, or by the Chairman of the Board.
|
| · |
reviewing and monitoring our compliance with our Corporate Governance Principles, Code of Conduct and Ethics for Employees, Officers and Directors, and Code of Conduct and Ethics for Senior Financial Officers;
|
| · |
periodically evaluating the size, composition, and independence of the Board of Directors and its committees, including applicable NASDAQ listing standards for independence;
|
| · |
evaluating individuals to be considered for Board service;
|
| · |
recommending director nominees to the Board;
|
| · |
overseeing the process to assess Board and committee effectiveness;
|
| · |
making recommendations to the Board with respect to committee assignments;
|
| · |
in consultation with the Compensation Committee, reviewing and recommending director compensation; and
|
| · |
monitoring compliance with director and executive stock ownership guidelines.
|
| · |
monitoring and overseeing the integrity of our accounting and financial reporting process, audits, financial statements and systems of internal controls;
|
| · |
monitoring and overseeing the independence and performance of our external auditors, internal auditors, and outsourced internal audit consultants;
|
| · |
facilitating communication among the external auditors, management, internal auditors, and the outsourced internal audit consultants; and
|
| · |
maintaining oversight of the external and internal auditors, including the appointment, compensation, retention and, when considered necessary, the dismissal of the external auditors and the Chief Audit Executive.
|
| · |
reviewing, evaluating and recommending objectives relevant to the Chief Executive Officer’s compensation; evaluating the Chief Executive Officer’s performance relative to established goals; and reviewing, evaluating and recommending to the Board the Chief Executive Officer’s compensation, including amounts available for awards under incentive cash plans and equity-based plans;
|
| · |
reviewing, evaluating and recommending, in consultation with the Chief Executive Officer, goals relevant to the compensation of our other executive management; reviewing such officers’ performance in light of these goals and recommending to the Board such officers’ compensation, including amounts available for awards under cash incentive plans and equity-based plans, based on this evaluation;
|
| · |
reviewing the Company’s compensation practices and the relationship among risk, risk management, and compensation in light of the Company’s objectives, including its safety and soundness and the avoidance of practices that would encourage excessive risk;
|
| · |
establishing and administering our equity-based plans, and incentive cash compensation program for executive management;
|
| · |
reviewing, evaluating, and recommending in consultation with the Nominating and Corporate Governance Committee, the compensation to be paid to our directors and to directors of our affiliates for their service on the Board;
|
| · |
reviewing, evaluating and recommending succession planning and development for executive officers;
|
| · |
appointing the named fiduciaries and the plan administrator for employee benefit plans subject to Employee Retirement Information Security Act; approving the compensation for any named fiduciary who is not an employee; and receiving reports from and overseeing the named fiduciaries;
|
| · |
reviewing, evaluating, and recommending the terms of employment and severance agreements and arrangements for executive management, including any change of control and indemnification provisions, as well as other compensatory arrangements and perquisite programs for executive management;
|
| · |
reviewing and approving changes in our tax-qualified benefit plans that result in material changes in costs or the benefit levels provided and changes in a plan’s trustee, administrator, or service provider;
|
| · |
reviewing the compensation discussion and analysis included in the proxy statements of the Company, and approving the related Compensation Committee Report; and
|
| · |
reviewing and evaluating annually the independence of compensation committee consultants and legal advisors.
|
| · |
have the highest personal and professional ethics and integrity and whose values are compatible with our values;
|
| · |
have experience and achievements that have given them the ability to exercise and develop good business judgment;
|
| · |
have a willingness to devote the necessary time to the work of the Board and its committees, which includes being available for Board and committee meetings;
|
| · |
have an understanding of and commitment to the markets in which we operate;
|
| · |
are involved in other activities or interests that do not create a conflict with their responsibilities to the Company and its stockholders; and
|
| · |
have the capacity and desire to represent the balanced, best interests of our stockholders as a group, and not primarily a special interest group or constituency.
|
|
Name, Age,
Director Since,
Term Expiration
|
Experience, Qualifications, Attributes, Skills
|
|
|
DIRECTOR NOMINEES:
|
||
|
Timothy C. Harrison, 60,
director since 2013,
Nominee for term expiring in 2021
|
Business Experience:
Mr. Harrison is a principal of TCH Realty & Development
Co., LLC, and affiliated partnerships, which develop retail and office projects. Mr. Harrison is a licensed attorney in the State of New York and the Commonwealth of Pennsylvania.
Reasons why this person should serve as a director
: Mr. Harrison has extensive
knowledge of real estate development and real estate law and possesses strong risk assessment and leadership skills. Mr. Harrison is involved in local professional and community organizations, including Project Hospitality in Staten Island, New York, and as a director and Vice Chairman of the Northfield Bank Foundation. He also serves on the Board of Trustees and as Vice Chairman of the Board of Staten Island Academy and Chairman of the Board of Visitors of the Nelson A. Rockefeller Center for Public Policy and the Social Sciences at Dartmouth College.
|
|
|
Karen J. Kessler, 61,
director since 2013,
Nominee for term expiring in 2021
|
Business Experience:
Ms. Kessler is President of Evergreen Partners, Inc. and has
over 25 years of experience in the public relations industry, specializing in reputation management and communication counseling for both public and private corporations, large educational institutions and leading not-for-profits.
Reasons why this person should serve as a director
: Ms. Kessler has extensive
experience as a leader in the public relations/crisis communication industry. She is an annual NJBIZ Power 100 recipient, a 2018 ROI-NJ Power List Influencer, and frequent speaker on the topics of corporate and board best practices, corporate reputation, and women in leadership. Her commentary and interviews have appeared in the Wall Street Journal, the New York Times, the Washington Post, the Star
|
|
Name, Age,
Director Since,
Term Expiration
|
Experience, Qualifications, Attributes, Skills
|
|
|
Ledger, and on CNN, MSNBC, and Inside Edition, among others.
Ms. Kessler currently chairs the Institute for Ethical Leadership at Rutgers University Business School, is a member of the NJ Advisory Committee on Judicial Conduct, a Visiting Fellow at the Rutgers Eagleton Institute of Politics, and a Director of Cinram Group, Inc. Previously, Ms. Kessler chaired the Board of AllSpire Health Partners, the nation’s largest health consortium, and Atlantic Health System. Ms. Kessler possesses strong skills in risk management, communication, economics, governance, and leadership.
|
||
|
Patrick L. Ryan, 68,
director since 2016,
Nominee for term expiring in 2021
|
Business Experience:
Mr. Ryan has over 19 years of community banking experience
and was the founder and chairman of Hopewell Valley Community Bank of Pennington, New Jersey, until it merged with Northfield Bank in January, 2016.
Reasons why this person should serve as a director
: In addition to his community
banking experience, Mr. Ryan has practiced law as an attorney, served as general manager of a specialty construction firm, and was Executive Vice President of Ritchie & Paige Distributing for 15 years. He is a member of the New Jersey and Virginia Bar Associations. Mr. Ryan is active in leadership roles in local professional and community organizations, including being the current President of the New Jersey Clean Communities Council, Chairman of the Joint Mercer Chambers Legislative Committee and a board member, Vice-Chair, Chair and Immediate Past Chair, of the Princeton Regional Chamber of Commerce.
|
|
|
Patrick E. Scura, Jr., 73,
director since 2006,
Nominee for term expiring in 2020 (Pursuant to the Company’s Bylaws, Mr. Scura will retire from the Board of Directors in May 2020)
|
Business Experience:
Mr. Scura was an audit partner with a national accounting and
auditing firm for 27 years.
Reasons why this person should serve as a director
: Mr. Scura is a former audit
partner with a national accounting and auditing firm, specializing in community banking, and has over 35 years experience auditing public company financial institutions. Mr. Scura is a licensed Certified Public Accountant, and has strong risk assessment, financial reporting, and internal control expertise. Mr. Scura has the requisite qualifications to be designated as an audit committee financial expert under the SEC’s rules and regulations. Mr. Scura also has extensive knowledge of and relationships with community banks in our market area. Mr. Scura is involved in local professional and community organizations including St. Peter’s University and the American Institute of Certified Public Accountants.
|
|
|
DIRECTORS
CONTINUING IN
OFFICE:
|
||
|
John W. Alexander, 68,
director since 1997,
term expires in 2020
|
Business Experience:
Mr. Alexander joined Northfield Bank in 1997, and has served
as its Chairman of the Board since 1998, and Chairman of the Board of Northfield Bancorp, Inc. since 2002. Mr. Alexander previously served as Chief Executive Officer of Northfield Bank and Northfield Bancorp, Inc. from 1998 until his retirement in October 2017, and as President from 2006 through 2013.
Reasons why this person should serve as a director
: In addition to his industry
knowledge, Mr. Alexander has strong analytical and leadership skills and over the years has been involved with state and national professional organizations including having served as a director of the New York Bankers Association and the New Jersey Bankers Association. He is a former partner with two national accounting and auditing firms, and specialized in bank taxation and asset securitization. Mr. Alexander currently serves as a director of the American Bankers Mutual Insurance Company. He is active in the community serving on the Northwell Health System
|
|
Name, Age,
Director Since,
Term Expiration
|
Experience, Qualifications, Attributes, Skills
|
|
|
Staten Island Regional Executive Council and as a director of the Snug Harbor Cultural Center and Botanical Garden, and the Northfield Bank Foundation.
|
||
|
Annette Catino, 61,
director since 2003,
term expires in 2020
|
Business Experience:
Ms. Catino is a nationally recognized healthcare executive and
entrepreneur. She launched QualCare Alliance networks in 1991 and served as President and Chief Executive Officer through the sale and transition to Cigna (NYSE: CI), a global health service company, concluding her service in April 2017. Ms. Catino speaks throughout the country on topics of leadership, the future of healthcare policy, women in the workplace and entrepreneurship. Ms. Catino currently provides strategic advisory services to the health care industry as an independent consultant.
Reasons why this person should serve as a director:
Ms. Catino has over 35 years of
business experience in leadership in the healthcare industry and has worked extensively with municipal and state governmental entities. Ms. Catino has the requisite qualifications to be designated as an audit committee financial expert under the SEC’s rules and regulations. Ms. Catino is involved in local professional and community organizations including the Boards of Caucus Educational Corporation and the Val Skinner Foundation. She served on New Jersey Governor Christie’s transition committee on healthcare and in December, 2014, was appointed by Governor Christie to serve on University Hospital’s Board of Directors for a five-year term, where she chairs the Audit Committee. University Hospital is an authority of the State of New Jersey and complies with Governmental Accounting Standards Board. Ms. Catino was named Ernst & Young’s Entrepreneur of the Year in New Jersey and was also recognized as a National Finalist in the 2013 Ernst & Young Strategic Growth Forum. In 2014 she was named by NJBIZ as one of the 100 Most Powerful People in New Jersey, as well as one of the 50 Most Powerful People in New Jersey Health Care. In addition, she was named by New Jersey Monthly as one of the top 25 Leading Women Entrepreneurs in New Jersey. She also serves as Chairman of the Board of Pure Inventions, LLC, a privately held company that manufactures and distributes liquid, dietary supplements in the spa, wellness, and natural food markets.
|
|
|
John P. Connors, Jr., 61,
director since 2002,
term expires in 2020
|
Business Experience:
Mr. Connors is the managing partner of the law firm of
Connors & Connors, P.C., located in Staten Island, New York.
Reasons why this person should serve as a director
: Mr. Connors has over 30 years
of business experience as a practicing attorney. Mr. Connors is admitted to practice in the state and federal courts of New York and New Jersey and the District of Columbia. Mr. Connors is Chair of the Grievance Committee for the Second, Eleventh, and Thirteenth Judicial Districts, covering Brooklyn, Queens, and Staten Island. He is Past Chair of the New York State Bar Association Trial Section and Past President of the Richmond County Bar Association. He represents Fortune 500 corporations and the Archdiocese of New York. Mr. Connors has strong risk management skills and in-depth knowledge of contract and professional liability law related to key areas of the Company’s operations. Mr. Connors also has knowledge of and relationships with many of the residents and businesses located in Staten Island, New York. Mr. Connors is involved in local professional and community organizations including the Richmond County and New York State Bar Associations. He is a Trustee of Notre Dame Academy, and a director of the Snug Harbor Cultural Center and Northfield Bank Foundation.
|
|
|
Gil Chapman, 64,
director since 2005,
term expires in 2019
|
Business Experience:
Mr. Chapman has over 25 years of business experience, most
recently owning and operating an automobile dealership in Staten Island, New York.
Reasons why this person should serve as a director
: Mr. Chapman has strong
marketing, sales, and customer service assessment skills. Mr. Chapman has
|
|
Name, Age,
Director Since,
Term Expiration
|
Experience, Qualifications, Attributes, Skills
|
|
|
significant experience in employee development, training, and business management. Mr. Chapman also has extensive experience in actively supervising financial personnel while operating his automobile business and has the requisite qualifications to be designated as an audit committee financial expert under the SEC’s rules and regulations. Mr. Chapman is a National Association of Corporate Directors (NACD) Board Leadership Fellow, which is the highest designation of credentials attainable from the NACD. Mr. Chapman is also a board member of the Westfield Foundation of Westfield, New Jersey.
|
||
|
Steven M. Klein, 52,
director since 2013,
term expires in 2019
|
Business Experience:
Mr. Klein joined the Company in 2005 as Chief Financial
Officer. He was named Chief Operating Officer in 2011. He was appointed President effective February 1, 2013, and retained the title of Chief Operating Officer. Effective November 1, 2017, Mr. Klein was appointed Chief Executive Officer.
Reasons why this person should serve as a director
: Mr. Klein is a registered
Certified Public Accountant, with strong analytical and leadership skills. Mr. Klein has over 30 years experience in banking and financial reporting, including SEC reporting. He is involved in state and national professional organizations including the New York Bankers Association, the New Jersey Bankers Association, the American Bankers Association, the American Institute of Certified Public Accountants, and the New Jersey Society of Certified Public Accountants. Mr. Klein is a former audit partner with a national accounting and auditing firm, specializing in community banks. Mr. Klein is a Director of the Northfield Bank Foundation and the Middlesex Water Company, and a Trustee of Richmond University Medical Center.
|
|
|
Frank P. Patafio, 57,
director since 2013,
term expires in 2019
|
Business Experience:
Mr. Patafio serves as Senior Executive Vice President, Head
of Investments, and portfolio manager at RXR Realty, New York, New York, with interests in approximately $17.7 billion of assets containing over 23.1 million square feet of commercial space and approximately 6,300 multifamily and for-sale units. From 1999 until 2009, Mr. Patafio was a partner and Chief Financial Officer of The Praedium Group, New York, New York. In addition, Mr. Patafio is a principal in FJKP, LLC, and affiliated partnerships, which develop residential homes and own rental properties.
Reasons why this person should serve as a director
: Mr. Patafio has extensive
knowledge and experience in real estate development and operations in the New York City marketplace and is a licensed Certified Public Accountant in New York State. Mr. Patafio has the requisite qualifications to be designated as an audit committee financial expert under the SEC’s rules and regulations. Mr. Patafio possesses strong risk assessment skills in real estate investment, operations, and financing. Mr. Patafio is a director of the Northfield Bank Foundation, and serves on the Northwell Health System Staten Island Regional Executive Council.
|
|
Board
of Directors
|
Nominating and
Corporate
Governance
|
Compensation
Committee
|
Audit
Committee
|
|||||||||||||
|
Annual Fee
|
$
|
54,000
|
—
|
—
|
—
|
|||||||||||
|
Annual Fee-Chair
|
—
|
$
|
8,000
|
$
|
10,000
|
$
|
26,000
|
|||||||||
|
Annual Fee-Members
|
—
|
—
|
—
|
$
|
13,000
|
|||||||||||
|
Per Meeting Fee
|
—
|
$
|
1,100
|
$
|
1,100
|
—
|
||||||||||
|
Name
|
Fees earned or
paid in cash
($)
(1)
|
Stock award
(2)(4)
($)
|
Stock
options
(3)(4)
($)
|
All other
compensation
($)
(5)
|
Total
($)
|
|||||||||||||||
|
John W. Alexander
|
13,400
|
—
|
—
|
20,833
|
34,233
|
|||||||||||||||
|
Annette Catino
|
85,856
|
—
|
—
|
6,865
|
92,721
|
|||||||||||||||
|
Gil Chapman
|
81,923
|
—
|
—
|
6,865
|
88,788
|
|||||||||||||||
|
John P. Connors, Jr.
|
98,840
|
—
|
—
|
6,865
|
105,705
|
|||||||||||||||
|
Timothy C. Harrison
|
98,540
|
—
|
—
|
6,865
|
105,405
|
|||||||||||||||
|
Karen J. Kessler
|
88,607
|
—
|
—
|
6,865
|
95,472
|
|||||||||||||||
|
Susan Lamberti
(6)
|
36,850
|
—
|
—
|
6,865
|
43,715
|
|||||||||||||||
|
Frank P. Patafio
|
99,023
|
—
|
—
|
6,865
|
105,888
|
|||||||||||||||
|
Patrick L. Ryan
|
83,940
|
326,430
|
189,084
|
—
|
599,454
|
|||||||||||||||
|
Patrick E. Scura, Jr.
|
92,640
|
—
|
—
|
6,865
|
99,505
|
|||||||||||||||
| (1) |
Includes retainer payments, meeting fees, and committee and/or chairmanship fees earned during the calendar year, whether the director received payment of such amounts or elected to defer them.
|
| (2) |
Represents the aggregate grant date fair value of 19,500 shares of restricted stock of the Company awarded to Mr. Ryan on August 1, 2017, based on a grant date stock price of $16.74 per share. For further information see footnote 11 to the consolidated financial statements included in the Company’s Form 10-K for the fiscal year ended December 31, 2017.
|
| (3) |
Represents the aggregate grant date fair value of options to purchase 45,744 shares of Company common stock awarded to Mr. Ryan on August 1, 2017. The options vest in installments of 6,400 shares on May 27, 2018, 6,400 shares on May 27, 2019, 2,944 shares on May 27, 2020, 15,000 shares on June 11, 2018, and 15,000 shares on June 11, 2019, and have an exercise price of $16.74 per share. For further information see footnote 11 to the consolidated financial statements included in the Company’s Form 10-K for the fiscal year ended December 31, 2017.
|
| (4) |
At December 31, 2017, Mr. Ryan held 19,500 unvested shares of restricted stock and 45,744 unvested stock options with an exercise price of $16.74. Mr. Ryan was appointed to the Board of Directors in 2016. On August 1, 2017, the Board approved stock and option awards to Mr. Ryan that approximate the remaining vesting to occur on stock and option awards made to the other non-employee directors on June 11, 2014, and May 27, 2015.
|
| (5) |
All other compensation consists solely of dividends paid upon the vesting of restricted stock awards that were withheld while the restricted stock awards were unvested except for John W. Alexander, whose amount relates solely to fees paid to him under a transition consulting agreement entered into October 6, 2017. Dividends paid upon the vesting of restricted stock awards for Mr. Alexander are reported in the Summary Compensation Table. See EXECUTIVE COMPENSATION – Compensation Tables – Summary Compensation Table.
|
| (6) |
Ms. Lamberti retired from the Company effective May 24, 2017.
|
|
Outstanding Director Equity Awards at Fiscal Year-end
|
||||||||||||||||||||
|
Option Awards
|
Stock Awards
|
|||||||||||||||||||
|
Name
|
Grant Date
|
Number of
securities
underlying
unexercised
options
(exercisable)
(#)
|
Number of
securities
underlying
unexercised
options
(unexercisable)
(#)
|
Option
exercise
price
($)
|
Option
expiration
date
(1)
|
Number
of shares
or units
of stock
that
have not
vested
(#)
|
||||||||||||||
|
John W. Alexander
(2)
|
1/30/09
|
170,400
|
—
|
7.09
|
1/30/09
|
—
|
||||||||||||||
|
6/11/14
|
224,768
|
55,288
|
13.13
|
6/11/24
|
21,726
|
|||||||||||||||
|
5/27/15
|
90,000
|
35,803
|
14.76
|
5/27/25
|
15,027
|
|||||||||||||||
|
Annette Catino
|
1/30/09
|
97,220
|
—
|
7.09
|
1/30/19
|
—
|
||||||||||||||
|
6/11/14
|
45,000
|
30,000
|
13.13
|
6/11/24
|
12,000
|
|||||||||||||||
|
5/27/15
|
12,800
|
19,200
|
14.76
|
5/27/25
|
7,500
|
|||||||||||||||
|
Gil Chapman
|
1/30/09
|
87,220
|
—
|
7.09
|
1/30/19
|
—
|
||||||||||||||
|
6/11/14
|
45,000
|
30,000
|
13.13
|
6/11/24
|
12,000
|
|||||||||||||||
|
5/27/15
|
12,800
|
19,200
|
14.76
|
5/27/25
|
7,500
|
|||||||||||||||
|
John P. Connors, Jr.
|
1/30/09
|
97,220
|
—
|
7.09
|
1/30/19
|
—
|
||||||||||||||
|
6/11/14
|
45,000
|
30,000
|
13.13
|
6/11/24
|
12,000
|
|||||||||||||||
|
5/27/15
|
12,800
|
19,200
|
14.76
|
5/27/25
|
7,500
|
|||||||||||||||
|
Timothy C. Harrison
|
6/11/14
|
45,000
|
30,000
|
13.13
|
6/11/24
|
12,000
|
||||||||||||||
|
5/27/15
|
12,800
|
19,200
|
14.76
|
5/27/25
|
7,500
|
|||||||||||||||
|
Karen J. Kessler
|
6/11/14
|
45,000
|
30,000
|
13.13
|
6/11/24
|
12,000
|
||||||||||||||
|
5/27/15
|
12,800
|
19,200
|
14.76
|
5/27/25
|
7,500
|
|||||||||||||||
|
Frank P. Patafio
|
6/11/14
|
45,000
|
30,000
|
13.13
|
6/11/24
|
12,000
|
||||||||||||||
|
5/27/15
|
12,800
|
19,200
|
14.76
|
5/27/25
|
7,500
|
|||||||||||||||
|
Patrick L. Ryan
|
8/01/17
|
—
|
45,744
|
16.74
|
8/01/27
|
19,500
|
||||||||||||||
|
Patrick E. Scura, Jr.
|
1/30/09
|
93,000
|
—
|
7.09
|
1/30/19
|
—
|
||||||||||||||
|
6/11/14
|
45,000
|
30,000
|
13.13
|
6/11/24
|
12,000
|
|||||||||||||||
|
5/27/15
|
12,800
|
19,200
|
14.76
|
5/27/25
|
7,500
|
|||||||||||||||
| (1) |
Stock options expire if unexercised 10 years from the grant date.
|
| (2) |
The market value of Mr. Alexander’s shares of stock that have not vested is $371,3080 as to the awards made on June 11, 2014, and $256,661 as to the awards made on May 27, 2015, based on $17.08 per share which is the last reported closing price of the Company’s common stock on December 29, 2017.
|
|
Position
|
Multiple of Base Salary
|
|
Chief Executive Officer
|
5 times base salary
|
|
Chief Financial Officer
|
2 times base salary
|
|
Executive Vice Presidents
|
2 times base salary
|
| · |
a statement that the writer is a stockholder and is proposing a candidate for consideration by the Committee;
|
| · |
the name and address of the stockholder as they appear on our books, and number of shares of our common stock that are owned beneficially by such stockholder (if the stockholder is not a holder of record, appropriate evidence of the stockholder’s ownership will be required);
|
| · |
the name, address and contact information for the candidate, and the number of shares of our common stock that are owned by the candidate (if the candidate is not a holder of record, appropriate evidence of the stockholder’s ownership should be provided);
|
| · |
a statement of the candidate’s business and educational experience;
|
| · |
such other information regarding the candidate as would be required to be included in the proxy statement pursuant to SEC Regulation 14A;
|
| · |
a statement detailing any relationship between the candidate and Northfield Bancorp, Inc. and its affiliates;
|
| · |
a statement detailing any relationship between the candidate and any customer, supplier or competitor of Northfield Bancorp, Inc. or its affiliates;
|
| · |
detailed information about any relationship or understanding between the proposing stockholder and the candidate; and
|
| · |
a statement of the candidate that the candidate is willing to be considered and willing to serve as a director if nominated and elected.
|
| · |
forward the communication to the Director or Directors to whom it is addressed; or
|
| · |
attempt to handle the inquiry directly, or forward the communication for response by another employee of Northfield Bancorp, Inc. For example, a request for information about a financial statement matter may be forwarded to our Chief Financial Officer; or
|
| · |
not forward the communication if it is primarily commercial in nature, relates to an improper or irrelevant topic, or is unduly hostile, threatening, illegal, or otherwise inappropriate.
|
|
Equity compensation plans approved by stockholders
|
Number of
securities to be
issued upon
exercise of
outstanding
options and
rights
|
Weighted
average
exercise price
(1)
($)
|
Number of
securities
remaining
available for
issuance under
the plan
(2)
|
|||||||||
|
2008 Equity Incentive Plan:
|
||||||||||||
|
Restricted Stock
|
—
|
N/A
|
3,378
|
|||||||||
|
Stock Options
|
1,516,245
|
8.08
|
17,299
|
|||||||||
|
Total
|
1,516,245
|
N/A
|
20,677
|
|||||||||
|
2014 Equity Incentive Plan:
|
||||||||||||
|
Restricted Stock
|
—
|
N/A
|
148,816
|
|||||||||
|
Stock Options
|
3,104,442
|
13.63
|
330,273
|
|||||||||
|
Total
|
3,104,442
|
N/A
|
479,089
|
|||||||||
| (1) |
Exercise price relates only to stock options.
|
| (2) |
The 2008 and 2014 Equity Incentive Plans permit the Compensation Committee of the Board to award, at its discretion, the remaining securities available for issuance under the plans entirely in stock options.
|
| · |
Align the interests of our executives with those of our stockholders;
|
| · |
Offer competitive base salaries benchmarked to the 50
th
percentile of our peer group;
|
| · |
Achieve balance between:
|
| o |
short-term and long-term performance;
|
| o |
fixed- and performance-based compensation;
|
| o |
cash and equity;
|
| · |
Link annual cash incentive compensation directly to performance:
|
| o |
focused on the Company’s strategic objectives;
|
| o |
balanced between corporate and individual goals;
|
| o |
targeted to reasonable payouts compared to base salaries;
|
| · |
Provide equity incentives as a significant component of total compensation:
|
| o |
benchmarked to the market practices of other recently converted mutual holding companies;
|
| o |
vested over a number of years to focus on long-term performance;
|
| · |
“Claw back” incentive compensation if certain events occur, such as materially incorrect information or restatements of financial statements;
|
| · |
Promote ownership in the Company through:
|
| o |
robust stock ownership guidelines;
|
| o |
prohibitions against hedging and borrowing against Company stock;
|
| · |
Provide continuity of leadership through the select use of employment and change-in-control agreements:
|
| o |
aligned with current market practices by role;
|
| o |
no “evergreen” provisions;
|
| o |
using a “double-trigger” for payment;
|
| o |
excluding “gross-ups” for taxes;
|
| o |
payment formula weighted toward base salary and cash incentive compensation, with limited health and welfare benefits and no severance payments for retirement benefits;
|
| · |
Provide health, welfare, and retirement benefits comparable with other Company employees and perquisites comparable to executives in the community banking marketplace.
|
|
Bancorp, Inc.
|
First of Long Island Corp.
|
Peapack-Gladstone Financial Corp.
|
|
Beneficial Bancorp, Inc.
|
Flushing Financial Corp.
|
Provident Financial Services, Inc.
|
|
Bridge Bancorp, Inc.
|
Kearny Financial Corp.
|
Sun Bancorp, Inc.
|
|
Community Bank System, Inc.
|
Lakeland Bancorp, Inc.
|
TriState Capital Holdings, Inc.
|
|
ConnectOne Bancorp, Inc.
|
Northwest Bancshares, Inc.
|
TrustCo Bank Corp NY
|
|
Customers Bancorp, Inc.
|
Ocean First Financial Corp.
|
WSFS Financial Corp.
|
|
Dime Community Bancshares, Inc.
|
Oritani Financial Corp.
|
|
Name
|
Target Award
Opportunity
($)
|
Actual Award
(1)
($)
|
Actual Award as a
percentage of
Target Award
Opportunity
(%)
|
|||||||||
|
John W. Alexander
|
236,667
|
236,667
|
100.0
|
|||||||||
|
William R. Jacobs
|
97,500
|
102,375
|
105.0
|
|||||||||
|
Steven M. Klein
|
230,000
|
230,000
|
100.0
|
|||||||||
|
Kenneth J. Doherty
|
94,500
|
93,555
|
99.0
|
|||||||||
|
Michael J. Widmer
|
82,500
|
86,625
|
105.0
|
|||||||||
|
Robin Lefkowitz
|
67,500
|
54,000
|
80.0
|
|||||||||
|
(1)
|
Actual awards exclude discretionary bonuses.
|
| · |
a defined contribution 401(k) retirement plan and discretionary profit-sharing plan;
|
| · |
an employee stock ownership plan;
|
| · |
medical coverage (all employees share in a percentage of the cost, depending on their elections);
|
| · |
pre-tax health and dependent care spending accounts; and
|
| · |
group life insurance coverage (death benefit capped at $750,000, with the value of the death benefit over $50,000 being reported as taxable income to all employees).
|
| · |
all Named Executive Officers may participate in a nonqualified deferred compensation plan. The plan provides restoration of benefits capped under Northfield Bank’s broad-based benefits due to Internal Revenue Code salary limitations or limitations due to participation requirements under tax-qualified plans. The plan also permits elective salary and cash incentive award deferrals;
|
| · |
all Named Executive Officers are reimbursed for appropriate spousal expenses for attendance at business events;
|
| · |
all Named Executive Officers are provided a cellular allowance of up to $120 per month for business usage;
|
| · |
Mr. Klein is provided full-time use of a company-maintained vehicle and reimbursement for reasonable costs associated with a golf club membership; and
|
| · |
Messrs. Jacobs, Doherty, Widmer and Ms. Lefkowitz received a monthly automobile allowance of $875.
|
|
Summary Compensation Table
|
||||||||||||||||||||||||||||||
|
Name and
principal position
|
Year
|
Salary
($)
|
Stock
Awards
(2)
($)
|
Option
Awards
(3)
($)
|
Bonus
($)
|
Non-equity
incentive plan
compensation
($)
|
All other
compensation
(4)
($)
|
Total
($)
|
||||||||||||||||||||||
|
John W. Alexander,
(1)
|
2017
|
606,231
|
—
|
—
|
—
|
236,667
|
163,327
|
1,006,225
|
||||||||||||||||||||||
|
Chairman of the
|
2016
|
693,000
|
—
|
—
|
25,000
|
319,500
|
182,417
|
1,219,917
|
||||||||||||||||||||||
|
Board and Retired
|
2015
|
676,000
|
1,476,000
|
915,750
|
75,000
|
270,400
|
162,911
|
3,576,061
|
||||||||||||||||||||||
|
Chief Executive
|
||||||||||||||||||||||||||||||
|
Officer
|
||||||||||||||||||||||||||||||
|
Steven M. Klein,
(5)
|
2017
|
446,923
|
168,900
|
157,600
|
—
|
230,000
|
119,840
|
1,123,263
|
||||||||||||||||||||||
|
President and Chief
|
2016
|
415,000
|
—
|
—
|
25,000
|
191,250
|
115,480
|
746,730
|
||||||||||||||||||||||
|
Executive Officer
|
2015
|
405,000
|
1,033,200
|
549,450
|
45,000
|
162,000
|
100,871
|
2,295,521
|
||||||||||||||||||||||
|
William R. Jacobs,
|
2017
|
325,000
|
—
|
—
|
—
|
102,375
|
71,656
|
499,031
|
||||||||||||||||||||||
|
Executive Vice
|
2016
|
262,500
|
—
|
—
|
15,000
|
90,750
|
68,287
|
436,537
|
||||||||||||||||||||||
|
President and Chief
|
2015
|
220,000
|
369,000
|
244,200
|
25,000
|
55,000
|
56,919
|
970,119
|
||||||||||||||||||||||
|
Financial Officer
|
||||||||||||||||||||||||||||||
|
Kenneth J. Doherty,
|
2017
|
315,000
|
—
|
—
|
20,000
|
93,555
|
83,010
|
511,565
|
||||||||||||||||||||||
|
Executive Vice
|
2016
|
307,500
|
—
|
—
|
20,000
|
85,050
|
82,842
|
495,392
|
||||||||||||||||||||||
|
President and Chief
|
2015
|
300,000
|
590,400
|
305,250
|
35,000
|
102,690
|
72,718
|
1,406,058
|
||||||||||||||||||||||
|
Lending Officer
|
||||||||||||||||||||||||||||||
|
Michael J. Widmer,
|
2017
|
275,000
|
—
|
—
|
20,000
|
86,625
|
71,672
|
453,297
|
||||||||||||||||||||||
|
Executive Vice
|
2016
|
275,000
|
—
|
—
|
20,000
|
90,750
|
74,857
|
460,607
|
||||||||||||||||||||||
|
President, Operations
|
2015
|
275,000
|
369,000
|
203,500
|
30,000
|
94,875
|
66,959
|
1,039,334
|
||||||||||||||||||||||
|
Robin Lefkowitz,
|
2017
|
225,000
|
—
|
—
|
—
|
54,000
|
52,949
|
331,949
|
||||||||||||||||||||||
|
Executive Vice
|
2016
|
207,500
|
368,800
|
197,600
|
—
|
73,050
|
55,124
|
902,074
|
||||||||||||||||||||||
|
President, Business
|
2015
|
170,000
|
—
|
40,700
|
—
|
51,000
|
33,789
|
295,489
|
||||||||||||||||||||||
|
Development Officer
|
||||||||||||||||||||||||||||||
| (1) |
Effective October 31, 2017, Mr. Alexander retired as Chief Executive Officer of Northfield Bank and the Company. Mr. Alexander entered into a transition consulting agreement with Northfield Bank and the Company on October 6, 2017. See “Corporate Governance and Board Matters – Directors Compensation,” for further discussion.
|
| (2) |
Represents the aggregate grant date fair value of restricted stock of the Company awarded to the employee during the applicable year. No forfeitures were assumed in calculating the aggregate grant date fair value. For 2017, compensation expense is based upon a grant date stock price of $16.89 per share, which was the final reported sales price of the Company’s common stock on the date of the grant. The restricted stock awards vest in equal installments over a two-year period, commencing one year from the date of the grant. For 2016, compensation expense is based upon a grant date stock price of $18.44 per share, which was the final reported sales price of the Company’s common stock on the date of the grant. The restricted stock awards vest in equal installments over a five-year period, commencing one year from the date of the grant. For 2015, compensation expense is based upon a grant date stock price of $14.76 per share, which was the final reported sales price of the Company’s common stock on the date of the grant. The restricted stock awards vest in equal installments over a five-year period, commencing one year from the date of the grant. For further information see footnote 11 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017.
|
| (3) |
Represents the aggregate grant date fair value of options to purchase Company common stock awarded to each employee during the applicable year. For 2017, options have an exercise price of $16.89 per share, which was the final reported sales price of the Company’s common stock on the date of the grant. The grant date fair value was $3.94 per option and was determined using the Black-Scholes method assuming an option’s average life of 5.75 years, 2.06% risk free rate of return, 29.22% volatility, and 2.37% dividend yield. For 2016, options have an exercise price of $18.44 per share, which was the final reported sales price of the Company’s common stock on the date of the grant. The grant date fair value was $4.94 per option and was determined using the Black-Scholes method assuming an option’s average life of 6.5 years, 1.8% risk free rate of return, 30.07% volatility, and 1.74% dividend yield. For 2015, options have an exercise price of $14.76 per share, which was the final reported sales price of the Company’s common stock on the date of the grant. The grant date fair value was $4.07 per option and was determined using the Black-Scholes method assuming an option’s average life of 6.5 years, 1.67% risk free rate of return, 32.06% volatility, and 1.90% dividend yield. No forfeitures were assumed in calculating the aggregate grant date fair value. For further information see footnote 11 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017.
|
| (4) |
The individuals listed in this table participate in certain medical and dental coverage plans, not disclosed in the Summary Compensation Table, that are generally available to salaried employees and do not discriminate in scope, terms, and operation. The amounts shown below for each individual for the year ended December 31, 2017, include our direct out-of-pocket costs (reduced for Messrs. Alexander and Klein, in the case of the figures shown for automobiles, by the amount that would otherwise have been paid in cash reimbursements during the year for business use) for the following items:
|
|
Mr. Alexander
|
Mr. Klein
|
Mr. Jacobs
|
Mr. Doherty
|
Mr. Widmer
|
Ms. Lefkowitz
|
|||||||||||||||||||
|
Employer contributions to qualified and nonqualified deferred compensation plans
|
$
|
94,714
|
$
|
69,450
|
$
|
49,170
|
$
|
48,719
|
$
|
42,759
|
$
|
35,383
|
||||||||||||
|
Automobile
|
14,004
|
18,195
|
10,500
|
10,500
|
10,500
|
10,500
|
||||||||||||||||||
|
Club dues
|
11,836
|
—
|
—
|
—
|
—
|
—
|
||||||||||||||||||
|
Dividends paid on restricted stock awards
(a)
|
39,790
|
28,120
|
8,568
|
19,120
|
14,620
|
3,460
|
||||||||||||||||||
|
Other
(b)
|
2,983
|
4,075
|
3,418
|
4,671
|
3,793
|
3,606
|
||||||||||||||||||
|
Total
|
$
|
163,327
|
$
|
119,840
|
$
|
71,656
|
$
|
83,010
|
$
|
71,672
|
$
|
52,949
|
||||||||||||
| (a) |
Amounts represent dividends paid upon the vesting of restricted stock awards that were withheld while the restricted stock awards were unvested.
|
| (b) |
Includes spousal reimbursement for business travel, welfare benefits, and cell phone and data usage.
|
| (5) |
Effective November 1, 2017, Mr. Klein was appointed Chief Executive Officer of Northfield Bank and the Company.
|
|
Grants of Plan-based Awards Table
|
||||||||||||||||||||||||||||||||||
|
Name
|
Grant date
|
Estimated future payouts under non-
equity incentive plan awards
|
All other
stock
awards:
number of
shares of
|
All other
option
awards:
number of
securities
|
Exercise or
base price of
|
Grant date
fair value of
|
||||||||||||||||||||||||||||
|
Threshold
($)
|
Target
($)
|
Maximum
($)
|
stock or
units (#)
|
underlying
options (#)
|
option awards
($/Share)
|
stock option
awards
(2)
|
||||||||||||||||||||||||||||
|
John W. Alexander
(1)
|
1/25/17
|
118,333
|
236,667
|
355,000
|
—
|
—
|
—
|
—
|
||||||||||||||||||||||||||
|
Steven M. Klein
|
1/25/17
|
115,000
|
230,000
|
345,000
|
||||||||||||||||||||||||||||||
|
11/1/17
|
10,000
|
40,000
|
$
|
16.89
|
$
|
3.94
|
||||||||||||||||||||||||||||
|
William R. Jacobs
|
1/25/17
|
48,750
|
97,500
|
146,250
|
—
|
—
|
—
|
—
|
||||||||||||||||||||||||||
|
Kenneth J. Doherty
|
1/25/17
|
47,250
|
94,500
|
141,750
|
—
|
—
|
—
|
—
|
||||||||||||||||||||||||||
|
Michael J. Widmer
|
1/25/17
|
41,250
|
82,500
|
123,750
|
—
|
—
|
—
|
—
|
||||||||||||||||||||||||||
|
Robin Lefkowitz
|
1/25/17
|
33,750
|
67,500
|
101,250
|
—
|
—
|
—
|
—
|
||||||||||||||||||||||||||
| (1) |
Figures are based on ten months of base salary due to Mr. Alexander’s retirement on October 31. 2017.
|
| (2) |
See footnotes 2 and 3 to the Summary Compensation Table for further information regarding grant date fair value of restricted stock and option awards.
|
|
Outstanding Equity Awards at Fiscal Year-end
Option Awards
|
Stock Awards
|
||||||||||||||||||||||
| Name |
Grant Date
|
Number of
securities
underlying
unexercised
options
(exercisable)
(#)
|
Number of
securities
underlying
unexercised
options
(unexercisable)
(#)
|
Option
exercise
price
($)
|
Option
expiration
date
(1)
|
Number
of shares
or units
of stock
that
have not
vested
(#)
|
Market
value of
shares or
units of
stock that
have not
vested
(2)
($)
|
||||||||||||||||
|
Steven M. Klein
|
1/30/09
|
217,730
|
—
|
7.09
|
1/30/19
|
—
|
—
|
||||||||||||||||
|
6/11/14
|
166,800
|
111,200
|
13.13
|
6/11/24
|
44,000
|
751,520
|
|||||||||||||||||
|
5/27/15
|
54,000
|
81,000
|
14.76
|
5/27/25
|
42,000
|
717,360
|
|||||||||||||||||
|
11/1/17
|
—
|
40,000
|
16.89
|
11/1/27
|
10,000
|
170,800
|
|||||||||||||||||
|
William R. Jacobs
|
6/11/14
|
28,200
|
18,800
|
13.13
|
6/11/24
|
12,400
|
211,792
|
||||||||||||||||
|
5/27/15
|
24,000
|
36,000
|
14.76
|
5/27/25
|
15,000
|
256,200
|
|||||||||||||||||
|
Kenneth J. Doherty
|
1/30/09
|
269,356
|
—
|
7.09
|
1/30/19
|
—
|
—
|
||||||||||||||||
|
6/11/14
|
124,200
|
82,800
|
13.13
|
6/11/24
|
32,000
|
546,560
|
|||||||||||||||||
|
5/27/15
|
30,000
|
45,000
|
14.76
|
5/27/25
|
24,000
|
409,920
|
|||||||||||||||||
|
Michael J. Widmer
|
6/11/14
|
102,000
|
68,000
|
13.13
|
6/11/24
|
26,000
|
444,080
|
||||||||||||||||
|
5/27/15
|
20,000
|
30,000
|
14.76
|
5/27/25
|
15,000
|
256,200
|
|||||||||||||||||
|
Robin Lefkowitz
|
1/30/09
|
11,856
|
—
|
7.09
|
1/30/19
|
—
|
—
|
||||||||||||||||
|
6/11/14
|
10,800
|
7,200
|
13.13
|
6/11/24
|
4,000
|
68,320
|
|||||||||||||||||
|
5/27/15
|
4,000
|
6,000
|
14.76
|
5/27/25
|
—
|
—
|
|||||||||||||||||
|
11/16/16
|
8,000
|
32,000
|
18.44
|
11/16/26
|
16,000
|
273,280
|
|||||||||||||||||
| (1) |
Stock options expire if unexercised 10 years from the grant date.
|
| (2) |
Amount is based on $17.08 per share which is the last reported closing price of the Company’s common stock on December 29, 2017.
|
|
Options Exercised and Stock Vested
|
||||||||||||||||
|
Option Awards
|
Stock Awards
|
|||||||||||||||
|
Name
|
Number of
Shares
Acquired on
Exercise
(#)
|
Value Realized
on Exercise
($)
|
Number of
Shares Acquired
on Vesting
(#)
|
Value
Realized on
Vesting
($)
|
||||||||||||
|
John W. Alexander
|
350,000
|
3,823,750
|
51,000
|
887,700
|
||||||||||||
|
Steven M. Klein
|
—
|
—
|
36,000
|
626,760
|
||||||||||||
|
William R. Jacobs
|
—
|
—
|
11,200
|
194,180
|
||||||||||||
|
Kenneth J. Doherty
|
—
|
—
|
24,000
|
419,520
|
||||||||||||
|
Michael J. Widmer
|
—
|
—
|
18,000
|
315,900
|
||||||||||||
|
Robin Lefkowitz
|
—
|
—
|
6,000
|
102,840
|
||||||||||||
|
Nonqualified Deferred Compensation at and for the Year Ended December 31, 2017
|
||||||||||||||||||||
|
Name
|
Executive
contributions in
last fiscal year
($)
(1)
|
Registrant
contributions in
last fiscal year
($)
(1)
|
Aggregate
earnings in last
fiscal year
($)
(2)
|
Aggregate
withdrawals/
distributions
($)
|
Aggregate balance
at last fiscal year
end
($)
(3)
|
|||||||||||||||
|
John W. Alexander
|
44,400
|
52,255
|
675,559
|
—
|
4,526,475
|
|||||||||||||||
|
Steven M. Klein
|
9,300
|
26,991
|
72,243
|
—
|
500,619
|
|||||||||||||||
|
William R. Jacobs
|
3,300
|
6,711
|
(74
|
)
|
—
|
9,937
|
||||||||||||||
|
Kenneth J. Doherty
|
2,552
|
6,260
|
66,101
|
—
|
436,939
|
|||||||||||||||
|
Michael J. Widmer
|
312
|
300
|
13,957
|
—
|
112,044
|
|||||||||||||||
|
Robin Lefkowitz
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||
| (1) |
Contributions included in the “Executive contributions in last fiscal year” and the “Registrant contributions in last fiscal year” columns are included as compensation for the listed individuals in the Summary Compensation Table.
|
| (2) |
Amounts included in the “Aggregate earnings in last fiscal year” are not included as compensation for the listed individuals in the Summary Compensation Table as such earnings are not preferential or “above market.”
|
| (3) |
Amounts included in the “Aggregate balance at last fiscal year end” previously were reported as compensation for the listed individuals except to the extent that such balances reflect earnings, all of which were not preferential or “above market.”
|
| (i) |
the failure to elect or reelect or to appoint or reappoint the executive to his employee position;
|
| (ii) |
a material change in the executive’s functions, duties, or responsibilities that would cause the executive’s position to become one of lesser responsibility, importance or scope;
|
| (iii) |
a relocation of the executive’s principal place of employment by more than 35 miles from designated areas;
|
| (iv) |
a material reduction in the benefits and perquisites of executive, other than a reduction in pay or benefits of all Northfield Bank employees;
|
| (v) |
the liquidation or dissolution of Northfield Bank or Northfield Bancorp, Inc. that would affect the status of the executive; or
|
| (vi) |
a material breach of the employment agreement by Northfield Bank;
|
|
Klein
|
Jacobs
|
Doherty
|
Widmer
|
Lefkowitz
|
||||||||||||||||
|
Disability
(1)
|
||||||||||||||||||||
|
Salary continuation
|
$
|
413,381
|
$
|
170,881
|
$
|
158,381
|
$
|
118,381
|
$
|
70,881
|
||||||||||
|
Acceleration of vesting of equity awards
(6)
|
2,274,440
|
625,772
|
1,387,940
|
1,038,480
|
383,960
|
|||||||||||||||
|
Medical, dental and other health benefits
|
21,108
|
72
|
15,108
|
21,108
|
72
|
|||||||||||||||
|
Total
|
$
|
2,708,929
|
$
|
796,725
|
$
|
1,561,429
|
$
|
1,177,969
|
$
|
454,913
|
||||||||||
|
Death
(2)
|
||||||||||||||||||||
|
Salary (lump-sum payment)
|
$
|
575,000
|
$
|
332,500
|
$
|
320,000
|
$
|
280,000
|
$
|
232,500
|
||||||||||
|
Acceleration of vesting of equity awards
(6)
|
2,274,440
|
625,772
|
1,387,940
|
1,038,480
|
383,960
|
|||||||||||||||
|
Medical, dental and other health benefits
|
21,108
|
72
|
15,180
|
21,108
|
72
|
|||||||||||||||
|
Total
|
$
|
2,870,548
|
$
|
958,344
|
$
|
1,723,120
|
$
|
1,339,588
|
$
|
616,532
|
||||||||||
|
Discharge Without Cause or Resignation With Good Reason
—
no Corporate Transaction
(3)
|
||||||||||||||||||||
|
Salary (lump sum)
|
$
|
1,725,000
|
$
|
665,000
|
$
|
640,000
|
$
|
560,000
|
$
|
465,000
|
||||||||||
|
Bonus (lump sum)
|
653,250
|
208,125
|
218,605
|
217,375
|
127,050
|
|||||||||||||||
|
Medical, dental and other health benefits
(4)
|
50,539
|
924
|
34,066
|
51,514
|
1,809
|
|||||||||||||||
|
Life insurance contributions
(4)
|
619
|
148
|
1,628
|
611
|
220
|
|||||||||||||||
|
Total
|
$
|
2,429,408
|
$
|
874,197
|
$
|
894,299
|
$
|
829,500
|
$
|
594,079
|
||||||||||
|
Discharge Without Cause or Resignation With Good Reason
—
Corporate Transaction
(5)
|
||||||||||||||||||||
|
Salary (lump sum)
|
$
|
1,725,000
|
$
|
665,000
|
$
|
640,000
|
$
|
560,000
|
$
|
465,000
|
||||||||||
|
Bonus (lump sum – see below)
(5)
|
||||||||||||||||||||
|
Relating to Change in Control
|
690,000
|
211,500
|
227,110
|
221,500
|
146,100
|
|||||||||||||||
|
Relating to Merger of Equals
|
653,250
|
208,125
|
218,605
|
217,375
|
127,050
|
|||||||||||||||
|
Acceleration of vesting of equity awards
(6)
|
2,274,440
|
625,772
|
1,387,940
|
1,038,480
|
383,960
|
|||||||||||||||
|
Medical, dental and other health benefits
|
50,539
|
924
|
34,066
|
51,514
|
1,809
|
|||||||||||||||
|
Life insurance contributions
|
619
|
148
|
1,628
|
611
|
220
|
|||||||||||||||
|
Total (Change in Control)
|
$
|
4,740,598
|
$
|
1,503,344
|
$
|
2,290,744
|
$
|
1,872,105
|
$
|
997,089
|
||||||||||
|
Total (Merger of Equals)
|
$
|
4,703,848
|
$
|
1,499,969
|
$
|
2,282,239
|
$
|
1,867,980
|
$
|
978,039
|
||||||||||
| (1) |
All Named Executive Officers receive, for one year following such disability, base salary continuation benefits and health benefits previously received. The employment agreement provides the executive with her or his base salary in the first year following disability, reduced by any assumed short-term or long-term disability insurance benefits provided under separate insurance plans we maintain. Such amounts due under the employment agreements are reduced by any assumed short-term or long-term disability insurance benefits provided under separate insurance plans on a tax-equivalent basis (assuming a 38% tax rate), if such short-term or long-term disability benefits are excludable for federal income tax purposes. Each Named Executive Officer also receives health benefits previously provided for a period of one year under the same terms immediately prior to termination due to disability.
|
| (2) |
Each of the employment agreements provides for a lump sum death benefit equal to one year of base salary for each executive. The employment agreements also provide for the continuation of medical, dental, and other health benefits to the executive’s family for a period of one year at the same terms and cost to the executive immediately prior to his death.
|
| (3) |
The employment agreement for Mr. Klein provides for the lump-sum payment of: three times base salary; three times the average annual bonus/and or incentive award for three years prior to the year of termination. Employment agreements for Messrs. Jacobs, Doherty, and Widmer and Ms. Lefkowitz provide for the lump-sum payment of: two times base salary; two times the average annual bonus/and or incentive award for two years prior to the year of termination.
|
| (4) |
Employment agreements for Messrs. Klein, Jacobs, Doherty, and Widmer, and Ms. Lefkowitz provide for medical, dental, and other health and welfare benefits to the executive and his family, at no cost to the executive for a period of 18 months from the date of termination. The reported figures reflect the estimated present value of the future health care premiums costs, calculated utilizing similar health care cost increase assumptions we used in measuring our liability for such benefits for financial statement purposes. For purposes of this presentation, the estimated future costs were discounted at a 2% annual compounding rate. The reported figures also include the estimated costs of group term life insurance benefits at a discount rate of 2% compounded annually.
|
| (5) |
Each employment agreement provides for severance benefits on termination following a corporate transaction, defined as a Change in Control, only if the executive’s employment is terminated involuntarily or they resign with Good Reason. Under each of the employment agreements, amounts payable under a Change in Control are identical to those payable for “Discharge Without Cause or Resignation With Good Reason — no Corporate Transaction” except that: (i) payments
|
| (6) |
Equity award agreements for all participants, including Named Executive Officers, provide for the acceleration of unvested equity awards in the event of disability, death, and in certain corporate transactions including a Change in Control as defined under the 2014 Equity Incentive Plan, and a Merger of Equals as defined in the related equity award agreements for all participants. The 2014 Equity Incentive Plan and related forms of equity award agreements have been filed as exhibits to the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. Forms of equity award agreements for option and equity awards made in 2015 have been filed with the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2015. The amounts reported represent the value of unvested equity awards at December 29, 2017, calculated as the sum of: (a) unvested shares of restricted stock multiplied by the last reported closing price of the Company’s common stock as reported on December 31, 2017, of $17.08 per share; and (b) unvested stock options multiplied by $3.95 per option for options awarded in 2014, $2.32 for options awarded in 2015, $0 for options awards in 2016, and $0.19 for options awarded in 2017. The $3.95 value of each option granted in 2014 represents the last reported closing price of the Company’s stock on December 29, 2017, less the 2014 option exercise price of $13.13. The $2.32 value of each option granted in 2015 represents the last reported closing price of the Company’s stock on December 29, 2017, less the 2015 option exercise price of $14.76. Options granted in 2016 have negative value based on the last reported closing price of the Company’s stock on December 29, 2017, less the 2016 option exercise price of $18.44. The $0.19 value of each option granted in 2017 represents the last reported closing price of the Company’s stock on December 29, 2017, less the 2017 option exercise price of $16.89
|
| · |
monitoring and overseeing the integrity of our accounting and financial reporting process, audits, financial statements and systems of internal controls;
|
| · |
monitoring and overseeing the independence and performance of our external auditors, internal auditors and outsourced internal audit consultants;
|
| · |
facilitating communication among the external auditors, management, internal auditors, and the outsourced internal audit consultants; and
|
| · |
maintaining oversight of the external and internal auditors, including the appointment, compensation, retention and, when considered necessary, the dismissal of the external auditors and the Chief Audit Executive.
|
| · |
monitors the preparation of quarterly and annual financial reports by the Company’s management;
|
| · |
evaluates the length of time the independent registered public accountants have provided services to the Company considering, among other things, their qualifications, industry expertise, and engagement team rotation policies. The Audit Committee also discusses professional practice matters, including training, audit quality processes, and regulatory report findings and related responses;
|
| · |
supervises the relationship between the Company and its independent registered public accountants, including: reviewing the scope of their audit services; approving audit and non-audit services; and confirming the independence of the independent registered public accountants;
|
| · |
oversees management’s implementation and maintenance of effective systems of internal and disclosure controls, and review of the Company’s internal auditing program; and
|
| · |
monitors financial reporting risks assigned to the Committee by the Board under the Company’s Enterprise Risk Management (ERM) program and reports thereon to the Board.
|
|
Year Ended
December 31,
|
Year Ended
December 31,
|
|||||||
|
2017
|
2016
|
|||||||
|
Audit Fees
|
$
|
610,000
|
$
|
566,000
|
||||
|
Audit-Related Fees
|
—
|
150,000
|
||||||
|
Name
(1)
|
Positions
Held in Northfield
Bancorp, Inc.
|
Shares of
Common Stock
Beneficially
Owned
(2)
|
Percent of
Class
|
|||
|
John W. Alexander
|
Director and Chairman of
|
910,136
(3)
|
1.8%
|
|||
|
the Board
|
||||||
|
Annette Catino
|
Director
|
341,590
(4)
|
*
|
|||
|
Gil Chapman
|
Director
|
143,707
(5)
|
*
|
|||
|
John P. Connors, Jr.
|
Director
|
297,551
(6)
|
*
|
|||
|
Timothy C. Harrison
|
Director
|
112,869
(7)
|
*
|
|||
|
Karen J. Kessler
|
Director
|
110,200
(8)
|
*
|
|||
|
Steven M. Klein
|
Director, President, and
Chief Executive Officer
|
839,360
(9)
|
1.6%
|
|||
|
Frank P. Patafio
|
Director
|
308,624
(10)
|
*
|
|||
|
Patrick L. Ryan
|
Director
|
289,423
(11)
|
*
|
|||
|
Patrick E. Scura, Jr.
|
Director
|
124,243
(12)
|
*
|
|||
|
Kenneth J. Doherty
|
Executive Vice President,
Chief Lending Officer
|
702,125
(13)
|
1.4%
|
|||
|
William R. Jacobs
|
Executive Vice President,
Chief Financial Officer
|
139,463
(14)
|
*
|
|||
|
Michael J. Widmer
|
Executive Vice President,
Operations
|
317,377
(15)
|
*
|
|||
|
Robin Lefkowitz
|
Executive Vice President,
Business Development
|
99,168
(16)
|
*
|
|||
|
All Directors and Executive Officers as a group (16 individuals)
|
4,735,832
|
9.2%
(17)
|
|
*
|
Less than 1%.
|
| (1) |
The mailing address for each person listed is 581 Main Street, Suite 810, Woodbridge, New Jersey, 07095.
|
| (2) |
See definition of “beneficial ownership” in the table “Voting Securities and Principal Holders Thereof.”
|
| (3) |
Includes 343,663 shares held jointly with Mr. Alexander’s spouse, and 32,618 shares allocated to Mr. Alexander under Northfield Bank’s ESOP. Also includes 497,102 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (4) |
Includes 61,280 shares held jointly with Ms. Catino’s spouse, 37,320 shares held in Ms. Catino’s IRA account, and 140 shares held in Ms. Catino’s SEP account. Also includes 64,200 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (5) |
Includes 7,500 shares held in Mr. Chapman’s IRA accounts, 29,111 shares held jointly with Mr. Chapman’s spouse and 6,610 shares held by Mr. Chapman’s spouse. Also includes 64,200 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (6) |
Includes 37,122 shares held in Mr. Connors’ IRA accounts, 16,738 shares held jointly with Mr. Connors’ spouse, and 841 shares held by Mr. Connors’ spouse. Also includes 161,420 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (7) |
Includes 64,200 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (8) |
Includes 3,500 shares held in Ms. Kessler’s IRA account. Also includes 64,200 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (9) |
Includes 47,689 shares held in Northfield Bank’s 401(k) Plan and 32,618 shares allocated to Mr. Klein under Northfield Bank’s ESOP. Also includes 440,530 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (10) |
Includes 105,500 shares held jointly with Mr. Patafio’s spouse and 52,150 shares held by Mr. Patafio’s spouse. Includes 64,200 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (11) |
Includes 183,259 shares held in family trusts, 7,000 shares held by Mr. Ryan’s spouse, 40,000 shares held in Mr. Ryan’s IRA, and 10,000 shares held by a limited liability company controlled by Mr. Ryan. Includes 6,400 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (12) |
Includes 10,521 shares held in Mr. Scura’s IRA account. Includes 64,200 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (13) |
Includes 27,168 shares held jointly with Mr. Doherty’s spouse, 3,368 shares held by Mr. Doherty’s spouse, 44,231 shares held in Northfield Bank’s 401(k) Plan, and 24,975 shares allocated to Mr. Doherty under Northfield Bank’s ESOP. Also includes 438,556 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (14) |
Includes 8,776 shares held in Northfield Bank’s 401(k) Plan, and 17,526 shares allocated to Mr. Jacobs under Northfield Bank’s ESOP. Also includes 64,200 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (15) |
Includes 24,029 shares held jointly with Mr. Widmer’s spouse, 5,896 shares held in Mr. Widmer’s IRA account, and 31,848 shares allocated to Mr. Widmer under Northfield Bank’s ESOP. Also includes 132,000 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (16) |
Includes 7,000 shares held jointly with Ms. Lefkowitz’ spouse, 14,167 shares held in Northfield Bank’s 401(k) Plan, and 17,912 shares allocated to Ms. Lefkowitz under Northfield Bank’s ESOP. Also includes 36,656 shares that may be acquired within 60 days of March 27, 2018, by exercising options.
|
| (17) |
Directors and executive officers beneficially owned 4,735,832 shares of common stock, or 9.2% of the outstanding shares. To calculate ownership percentages of all directors and executive officers as a group, outstanding shares at March 27, 2018, have been increased by 2,162,064 shares, representing options held by all directors and executive officers of Northfield Bancorp, Inc. that may be acquired within 60 days by exercising such options.
|
|
BY ORDER OF THE BOARD OF DIRECTORS
|
|
|
|
|
|
M. Eileen Bergin
|
|
|
Senior Vice President, Corporate Secretary
|
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
|
||
|
E43889-P04102
|
KEEP THIS PORTION FOR YOUR RECORDS
|
|
|
THIS PROXY IS VALID ONLY WHEN SIGNED AND DATED.
|
DETACH AND RETURN THIS PORTION ONLY
|
|
NORTHFIELD BANCORP, INC.
|
For
All
|
Withhold
All
|
For All
Except
|
To withhold authority to vote for any individual nominee(s), mark “For All Except” and write the number(s) of the nominee(s) on the line below.
|
||||||
|
The Board of Directors recommends you vote FOR the following:
|
||||||||||
|
I.
|
Election of Directors for the term shown
|
☐ | ☐ | ☐ | ||||||
|
Nominees:
|
||||||||||
|
|
01)
|
Timothy C. Harrison - three-year term
|
||||||||
|
|
02)
|
Karen J. Kessler - three-year term
|
||||||||
|
|
03)
|
Patrick L. Ryan - three-year term
|
||||||||
|
|
04)
|
Patrick E. Scura, Jr. - two-year term
|
||||||||
|
The Board of Directors recommends you vote FOR the following proposals:
|
For
|
Against
|
Abstain
|
||
|
II.
|
The ratification of the appointment of KPMG LLP as independent registered public accounting firm for the year ending December 31, 2018;
|
☐ | ☐ | ☐ | |
|
III.
|
An advisory, non-binding resolution, to approve the executive compensation described in the Proxy Statement; and
|
☐ | ☐ | ☐ | |
|
Such other business as may properly come before the meeting or any adjournment thereof.
|
|||||
|
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally, but only one signature is required. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.
|
|
|
||||||
|
Signature [PLEASE SIGN WITHIN BOX]
|
Date
|
Signature (Joint Owners)
|
Date
|
|
|
E43890-P04102
|
|
|
NORTHFIELD BANCORP, INC.
Annual Meeting of Stockholders
May 23, 2018 10:00 AM
This Proxy is solicited by the Board of Directors
The undersigned hereby appoints the full Board of Directors (other than those listed as nominees in this proxy), with full powers of substitution, to act as attorneys and proxies for the undersigned to vote all shares of common stock of Northfield Bancorp, Inc. (the “Company”) which the undersigned is entitled to vote at the Annual Meeting of Stockholders to be held at 581 Main Street, Suite 810, Woodbridge, NJ 07095, at 10:00 a.m. (local time) on May 23, 2018. The proxy committee is authorized to cast all votes to which the undersigned is entitled as follows. Should the stockholder be present and elect to vote at the Annual Meeting or at any adjournment thereof and after notification to the Secretary of Northfield Bancorp, Inc. at the Annual Meeting of the stockholder’s decision to terminate this proxy, then the power of said attorneys and proxies shall be deemed terminated and of no further force and effect. This proxy may also be revoked by sending written notice to the Secretary of Northfield Bancorp, Inc. at the address set forth on the Notice of Annual Meeting of Stockholders, or by the filing of a later proxy prior to a vote being taken on a particular proposal at the Annual Meeting. The stockholder acknowledges receipt from Northfield Bancorp, Inc. prior to the execution of this proxy of Notice of the Annual Meeting, audited financial statements and a proxy statement dated April 10, 2018. The Board of Directors recommends a vote “FOR” all nominees listed and “FOR” proposals II and III.
THIS PROXY WILL BE VOTED AS DIRECTED, BUT IF NO INSTRUCTIONS ARE SPECIFIED, THIS PROXY WILL BE VOTED FOR EACH OF THE PROPOSALS STATED. IF ANY OTHER BUSINESS IS PRESENTED AT THE ANNUAL MEETING, THIS PROXY WILL BE VOTED BY THE ABOVE-NAMED PROXIES AT THE DIRECTION OF A MAJORITY OF THE BOARD OF DIRECTORS. AT THE PRESENT TIME, THE BOARD OF DIRECTORS KNOWS OF NO OTHER BUSINESS TO BE PRESENTED AT THE ANNUAL MEETING.
Continued and to be signed on reverse side
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|